Table of Contents

1 Study Coverage

• 1.1 Smart Insulin Pens Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Smart Insulin Pens Market Size Growth Rate by Product
  • 1.4.2 Smart Insulin Pens
  • 1.4.3 Smart Pen Caps
• 1.5 Market by End User
  • 1.5.1 Global Smart Insulin Pens Market Size Growth Rate by End User
  • 1.5.2 Home Care Settings
  • 1.5.3 Hospitals & Clinics
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Smart Insulin Pens Market Size
  • 2.1.1 Global Smart Insulin Pens Revenue 2014-2025
  • 2.1.2 Global Smart Insulin Pens Sales 2014-2025
• 2.2 Smart Insulin Pens Growth Rate by Regions
  • 2.2.1 Global Smart Insulin Pens Sales by Regions
  • 2.2.2 Global Smart Insulin Pens Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Smart Insulin Pens Sales by Manufacturers
  • 3.1.1 Smart Insulin Pens Sales by Manufacturers
  • 3.1.2 Smart Insulin Pens Sales Market Share by Manufacturers
  • 3.1.3 Global Smart Insulin Pens Market Concentration Ratio (CR5 and HHI)
• 3.2 Smart Insulin Pens Revenue by Manufacturers
  • 3.2.1 Smart Insulin Pens Revenue by Manufacturers (2014-2019)
  • 3.2.2 Smart Insulin Pens Revenue Share by Manufacturers (2014-2019)
• 3.3 Smart Insulin Pens Price by Manufacturers
• 3.4 Smart Insulin Pens Manufacturing Base Distribution, Product Types
  • 3.4.1 Smart Insulin Pens Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Smart Insulin Pens Product Type
  • 3.4.3 Date of International Manufacturers Enter into Smart Insulin Pens Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Smart Insulin Pens Sales by Product
• 4.2 Global Smart Insulin Pens Revenue by Product
• 4.3 Smart Insulin Pens Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Smart Insulin Pens Breakdown Data by End User

6 North America

• 6.1 North America Smart Insulin Pens by Countries
  • 6.1.1 North America Smart Insulin Pens Sales by Countries
  • 6.1.2 North America Smart Insulin Pens Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Smart Insulin Pens by Product
• 6.3 North America Smart Insulin Pens by End User

7 Europe

• 7.1 Europe Smart Insulin Pens by Countries
  • 7.1.1 Europe Smart Insulin Pens Sales by Countries
  • 7.1.2 Europe Smart Insulin Pens Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Smart Insulin Pens by Product
• 7.3 Europe Smart Insulin Pens by End User

8 Asia Pacific

• 8.1 Asia Pacific Smart Insulin Pens by Countries
  • 8.1.1 Asia Pacific Smart Insulin Pens Sales by Countries
  • 8.1.2 Asia Pacific Smart Insulin Pens Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Smart Insulin Pens by Product
• 8.3 Asia Pacific Smart Insulin Pens by End User

9 Central & South America

• 9.1 Central & South America Smart Insulin Pens by Countries
  • 9.1.1 Central & South America Smart Insulin Pens Sales by Countries
  • 9.1.2 Central & South America Smart Insulin Pens Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Smart Insulin Pens by Product
• 9.3 Central & South America Smart Insulin Pens by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Smart Insulin Pens by Countries
  • 10.1.1 Middle East and Africa Smart Insulin Pens Sales by Countries
  • 10.1.2 Middle East and Africa Smart Insulin Pens Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Smart Insulin Pens by Product
• 10.3 Middle East and Africa Smart Insulin Pens by End User

11 Company Profiles

• 11.1 Emperra
  • 11.1.1 Emperra Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Emperra Smart Insulin Pens Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Emperra Smart Insulin Pens Products Offered
  • 11.1.5 Emperra Recent Development
• 11.2 Roche
  • 11.2.1 Roche Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Roche Smart Insulin Pens Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Roche Smart Insulin Pens Products Offered
  • 11.2.5 Roche Recent Development
• 11.3 Diamesco
  • 11.3.1 Diamesco Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Diamesco Smart Insulin Pens Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Diamesco Smart Insulin Pens Products Offered
  • 11.3.5 Diamesco Recent Development
• 11.4 Companion Medical
  • 11.4.1 Companion Medical Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Companion Medical Smart Insulin Pens Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Companion Medical Smart Insulin Pens Products Offered
  • 11.4.5 Companion Medical Recent Development
• 11.5 Patients Pending
  • 11.5.1 Patients Pending Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Patients Pending Smart Insulin Pens Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Patients Pending Smart Insulin Pens Products Offered
  • 11.5.5 Patients Pending Recent Development
• 11.6 Common Sensing
  • 11.6.1 Common Sensing Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Common Sensing Smart Insulin Pens Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Common Sensing Smart Insulin Pens Products Offered
  • 11.6.5 Common Sensing Recent Development
• 11.7 Jiangsu Delfu
  • 11.7.1 Jiangsu Delfu Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Jiangsu Delfu Smart Insulin Pens Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Jiangsu Delfu Smart Insulin Pens Products Offered
  • 11.7.5 Jiangsu Delfu Recent Development
• 11.8 Dnurse
  • 11.8.1 Dnurse Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Dnurse Smart Insulin Pens Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Dnurse Smart Insulin Pens Products Offered
  • 11.8.5 Dnurse Recent Development

12 Future Forecast

• 12.1 Smart Insulin Pens Market Forecast by Regions
  • 12.1.1 Global Smart Insulin Pens Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Smart Insulin Pens Revenue Forecast by Regions 2019-2025
• 12.2 Smart Insulin Pens Market Forecast by Product
  • 12.2.1 Global Smart Insulin Pens Sales Forecast by Product 2019-2025
  • 12.2.2 Global Smart Insulin Pens Revenue Forecast by Product 2019-2025
• 12.3 Smart Insulin Pens Market Forecast by End User
• 12.4 North America Smart Insulin Pens Forecast
• 12.5 Europe Smart Insulin Pens Forecast
• 12.6 Asia Pacific Smart Insulin Pens Forecast
• 12.7 Central & South America Smart Insulin Pens Forecast
• 12.8 Middle East and Africa Smart Insulin Pens Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Smart Insulin Pens Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Smart Insulin Pens is an electronic medical records device that reminds patient to take your medicine or tracks how much medicine patient taken.
Europe region is the largest supplier of Smart Insulin Pens, with a production market share nearly 71% in 2017.
Europe is the largest consumption place, with a consumption market share nearly 70.2% in 2017. Following Europe, North America is the second largest consumption place with the consumption market share of 12.9%.
The global Smart Insulin Pens market is valued at 8 million US$ in 2018 and will reach 16 million US$ by the end of 2025, growing at a CAGR of 8.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Smart Insulin Pens market based on company, product type, end user and key regions.

This report studies the global market size of Smart Insulin Pens in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Smart Insulin Pens in these regions.
This research report categorizes the global Smart Insulin Pens market by top players/brands, region, type and end user. This report also studies the global Smart Insulin Pens market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Emperra
Roche
Diamesco
Companion Medical
Patients Pending
Common Sensing
Jiangsu Delfu
Dnurse

Market size by Product
Smart Insulin Pens
Smart Pen Caps
Market size by End User
Home Care Settings
Hospitals & Clinics
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Smart Insulin Pens market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Smart Insulin Pens market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Smart Insulin Pens companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Smart Insulin Pens submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Smart Insulin Pens are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Smart Insulin Pens market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.